| Dr Cynthia M Brennan, MD | |
|
9100 N May Ave, Oklahoma City, OK 73120-4417 | |
| (405) 840-4456 | |
| (405) 840-4295 |
| Full Name | Dr Cynthia M Brennan |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 9100 N May Ave, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013910264 | NPI | - | NPPES |
| 200130090A | Medicaid | OK | |
| 289638 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | AZ 19008 (Arizona) | Secondary |
| 207Q00000X | Family Medicine | 14390 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cynthia M Brennan, MD 9100 N May Ave, Oklahoma City, OK 73120-4417 Ph: (405) 840-4456 | Dr Cynthia M Brennan, MD 9100 N May Ave, Oklahoma City, OK 73120-4417 Ph: (405) 840-4456 |
News Archive
Chicago officials are teaming up with Blue Cross and Blue Shield of Illinois on health care fraud detection and prevention. A task force will be made up of representatives of the city and the health insurer. Members will work to assess potential health care fraud and instances of wasteful spending.
Seaside Therapeutics, Inc. announced today data from the largest randomized, placebo-controlled study conducted to date in individuals with fragile X syndrome. In a Phase 2 study of STX209, clinically meaningful improvements on global and specific neurobehavioral outcomes were observed in the general study population. The improvements were statistically significant in pediatric patients with more severe impairments in sociability - a core symptom of fragile X syndrome.
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for both large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced that the European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Omidria® (phenylephrine and ketorolac injection) 1%/0.3%.
A leading cancer expert has issued a warning about eating processed meats such as sausages.
› Verified 1 days ago
Alyssa Penick, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 608 Nw 9th St Ste 1100, Oklahoma City, OK 73102 Phone: 405-231-3000 | |
Dr. Carl Patrick Griffin, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 3555 Nw 58th St, Suite 801, Oklahoma City, OK 73112 Phone: 405-840-7003 Fax: 405-840-8221 | |
Dewey C Scheid, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Ne 10th St, Oklahoma City, OK 73104 Phone: 405-271-4311 Fax: 405-271-2797 | |
Dr. Johnaqa Saidi, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9220 S Pennsylvania Ave Ste A, Oklahoma City, OK 73159 Phone: 405-691-4497 Fax: 405-692-8807 | |
Mrs. Lauren Cathleen Hopkins, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3500 Nw 56th St Ste 100, Oklahoma City, OK 73112 Phone: 405-951-2855 | |
Dr. Gurdeep Singh Grewal, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 900 Ne 10th St, Oklahoma City, OK 73104 Phone: 405-271-4311 |